Statistical analysis showed that high HDAC1 or HDAC4 mRNA expression was significantly correlated with advanced clinical stage (P=0.003 or 0.030, respectively) and poor tumor response of patients (P=0.004 or 0.001, respectively). Here, HDAC4 is linked to neoplasm.